Corbus Pharmaceuticals (CRBP) vs Quantum Cyber N.V. (QUCY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Quantum Cyber N.V. (QUCY) has outperformed Corbus Pharmaceuticals (CRBP) over the past year, losing 13.1% versus a loss of 60.7%. Quantum Cyber N.V. is the larger company by market cap ($115.3 million vs $101.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRBP | QUCY |
|---|---|---|
| Share price | $5.26 | $1.37 |
| Market cap | $101.74M | $115.29M |
| 1-day change | -0.19% | -1.34% |
| YTD return | -35.26% | +24.11% |
| 1-year return | -60.73% | -13.13% |
| 5-year return | -82.78% | — |
| EPS (TTM) | $-6.11 | $-2.41 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $20.56 | $4.93 |
| 52-week low | $5.13 | $0.30 |
| Distance from 52-week high | -74.42% | -72.18% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +546.96% | +556.26% |
| Average volume | 756.54K | 691.24K |
| Shares outstanding | 19.34M | 84.07M |
| Employees | 36 | 10 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QUCY has outperformed CRBP by 47.6 percentage points over the past year.
About Corbus Pharmaceuticals
CRBP stock →Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity.
Health Care · Biotechnology: Pharmaceutical Preparations · 36 employees
About Quantum Cyber N.V.
QUCY stock →Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
CRBP vs QUCY FAQ
Which is bigger, Corbus Pharmaceuticals or Quantum Cyber N.V.?
Quantum Cyber N.V. (QUCY) is larger, with a market capitalization of $115.29M compared with $101.74M for Corbus Pharmaceuticals (CRBP).
Which stock has performed better over the past year, CRBP or QUCY?
QUCY returned -13.13% over the past 12 months, compared with -60.73% for CRBP (price return, excluding dividends). Past performance does not predict future results.
Are Corbus Pharmaceuticals and Quantum Cyber N.V. in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.